TimesSquare Capital Management, LLC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1313816 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$26,981,930

+$2,910,795 QoQ

Shares Held

796,162

+5.9% QoQ

Ownership

0.666%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#27

of 198 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

TimesSquare Capital Management, LLC holds $522,649,738 across 18 Biotechnology names. NAMS ranks #7 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	728,096	$77,629,595
2	ARGX	Argenx SE	83,114	$77,110,675
3	IONS	Ionis Pharmaceuticals Inc	614,070	$48,689,610
4	MIRM	Mirum Pharmaceuticals, Inc.	367,281	$42,997,586
5	KRYS	Krystal Biotech, Inc.	111,545	$41,457,930
6	XENE	Xenon Pharmaceuticals Inc.	451,593	$27,258,153
7	NAMS	NewAmsterdam Pharma Co N.V. This page	796,162	$26,981,930
8	VCEL	Vericel Corp	549,846	$24,462,648

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,981,930	796,162	+5.9%	Shares	Sole	2026-08-07
2026-03-31	$24,071,135	751,988	-8.6%	Shares	Sole	2026-05-07
2025-12-31	$28,846,284	822,300	-1.8%	Shares	Sole	2026-02-06
2025-09-30	$23,814,745	837,368	-4.0%	Shares	Sole	2025-11-07
2025-06-30	$15,801,645	872,537	-2.1%	Shares	Sole	2025-08-08
2025-03-31	$18,240,571	891,088	-0.5%	Shares	Sole	2025-05-02
2024-12-31	$23,016,251	895,574	+250.9%	Shares	Sole	2025-02-03
2024-09-30	$4,237,067	255,245	+3.7%	Shares	Sole	2024-11-04
2024-06-30	$4,727,292	246,085	+7.6%	Shares	Sole	2024-08-08
2024-03-31	$5,406,768	228,616	—	Shares	Sole	2024-05-07
No filing history on record for this holder in this stock.